Bladder Cancer

On this page

Epidemiology & Risk Factors - Bladder's Bad Bets

  • Incidence: Common; Men > Women (~3:1). Peak: 60-70 yrs.
  • Higher in industrialized nations.
  • Major Risk Factors:
    • ⭐ Smoking: Single largest risk factor, ~50% cases. Risk ↑ with duration/intensity.

    • Occupational: Aromatic amines (benzidine, β-naphthylamine) in dye, rubber, textile, paint industries.
    • Chronic Bladder Irritation: Schistosomiasis (↑ Squamous Cell Carcinoma risk), chronic UTIs, stones.
    • Drugs: Cyclophosphamide, phenacetin.
    • Pelvic Irradiation.
    • Genetic: Lynch syndrome, NAT & GST polymorphisms.
    • Aristolochic acid (herbal remedies). 📌 Mnemonic (Chemicals): "Pee SAC" (Phenacetin, Smoking, Aniline dyes, Cyclophosphamide). oka

Pathology & Staging - Cancer's ID Card

  • Histological Types:
    • Urothelial (Transitional Cell) Carcinoma (TCC): >90% of cases.
      • Papillary: Most common, often low grade, better prognosis.
      • Flat (Carcinoma In Situ - CIS): High grade, aggressive potential if untreated.
    • Squamous Cell Carcinoma (SCC): ~5% (associated with chronic irritation, Schistosomiasis).
    • Adenocarcinoma: <2% (often from urachal remnant or bladder exstrophy).

⭐ Urothelial (Transitional Cell) Carcinoma is the most common type (>90%).

  • TNM Staging (AJCC 8th Ed. Overview): Defines tumor extent, nodal spread, and metastasis.
    • T (Primary Tumor): Depth of bladder wall invasion.
      • Non-Muscle Invasive Bladder Cancer (NMIBC): Ta (non-invasive papillary), Tis (CIS), T1 (invades lamina propria).
      • Muscle Invasive Bladder Cancer (MIBC): T2 (invades muscularis propria), T3 (invades perivesical fat/tissue), T4 (invades adjacent organs e.g., prostate, uterus, pelvic wall).
    • N (Regional Lymph Nodes): N0 (no lymph node spread) to N3 (spread to common iliac nodes).
    • M (Distant Metastasis): M0 (no distant spread) or M1 (distant sites e.g., lung, liver, bone).

Bladder Cancer T Stages and Wall Layers

Clinical Features & Diagnosis - Spotting the Trouble

⭐ Painless gross hematuria is the classic presenting symptom, seen in 80-90% of patients.

  • Key Symptoms:
    • Painless visible hematuria (most frequent).
    • Irritative voiding: Dysuria, frequency, urgency (esp. with CIS).
    • Advanced: Pelvic/flank pain (obstruction), constitutional symptoms.
  • Diagnostic Steps:
    1. Urine Evaluation:
      • Urinalysis, Cytology (High Sp for High-Grade/CIS).
      • Tumor Markers (NMP22, BTA): Adjunctive.
    2. Cystoscopy & TURBT:
      • Gold standard for diagnosis & initial staging (T-stage, grade).
      • Allows biopsy/resection.
      • 📌 Bimanual Exam Under Anesthesia (BEUA) during TURBT assesses local invasion.
    3. Imaging for Staging:
      • CT Urography (CTU): Evaluates entire urothelium; stages local/nodal/distant disease.
      • MRI: Detailed local staging.
      • Chest/Bone Scan: Metastatic workup for Muscle-Invasive Bladder Cancer (MIBC).

Cystoscopy and CT Urogram of Bladder Cancer

Management Principles - Battling the Bulge

  • Goal: Cure, Bladder Preservation, QoL.
  • NMIBC (Ta, T1, CIS):
    • Transurethral Resection of Bladder Tumor (TURBT) is diagnostic & therapeutic.
    • Adjuvant Intravesical Therapy:
      • Low Risk: Single Mitomycin C dose.
      • Intermediate Risk: Mitomycin C or BCG.
      • High Risk: BCG (Bacillus Calmette-Guérin).

⭐ Intravesical BCG is the mainstay for high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) after TURBT.

  • MIBC (≥T2):
    • Neoadjuvant Chemotherapy (NAC) with Cisplatin (if fit) improves survival.
    • Radical Cystectomy (RC) + Pelvic Lymph Node Dissection (PLND) = Gold Standard.
    • Urinary Diversion: Ileal conduit, Orthotopic neobladder.
    • Bladder Preservation: Trimodal Therapy (TURBT + Chemo + RT) in select patients.
  • Metastatic (M1): Systemic Chemo, Immunotherapy.

High-Yield Points - ⚡ Biggest Takeaways

  • Transitional Cell Carcinoma (TCC) is the most common type (>90%).
  • Painless gross hematuria is the classic presenting symptom.
  • Cigarette smoking is the single most important risk factor. Others: aromatic amines, cyclophosphamide.
  • Cystoscopy with biopsy is the gold standard for diagnosis and staging.
  • NMIBC (Non-Muscle Invasive): TURBT + intravesical BCG (most effective for high-risk).
  • MIBC (Muscle Invasive): Radical cystectomy ± neoadjuvant chemotherapy (improves survival).

Practice Questions: Bladder Cancer

Test your understanding with these related questions

A 50 year old male patient came to the outpatient department with complaints of hematuria. A 2 x 2 cm bladder mass is seen which is low grade transitional cell carcinoma. Which among the following is the ideal management?

1 of 5

Flashcards: Bladder Cancer

1/10

What is the treatment of choice for Bosniak 3?_____

TAP TO REVEAL ANSWER

What is the treatment of choice for Bosniak 3?_____

Partial nephrectomy or radiofrequency ablation

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial